Genocea Biosciences
Biotechnology
Cambridge, Massachusetts
Public Corporation
Our Company
Genocea finds targets of T cell responses to discover and develop life-changing medicines. We’ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases. Genocea's pipeline of novel T cell vaccines includes GEN-003 for HSV-2 therapy and GEN-004, a protein vaccine directed at pneumococcus, both currently in Phase II clinical trials.Skills We're Looking For
Assessments
Data Analysis
Design
Manufacturing
Optimization
Chemical Engineering
Liaise
Current Good Manufacturing Practice (CGMP)
Akta Avant
Diafiltration (DF)
Ultrafiltration (UF)
Quality by Design (QbD)
Design Of Experiments (DOE)
Design Space
Scale-Up Model
Scale-Down Model
Biochemical Engineering
